Plain-English translation of NCT00001184 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at the National Institute of Allergy and Infectious Diseases want to understand why some people develop inflammatory bowel diseases like Crohn's disease and ulcerative colitis. This study collects blood samples, tissue biopsies, and genetic information from patients with these conditions—and from healthy volunteers—to identify the molecular and immune system problems that trigger the disease. By understanding these root causes, researchers hope to develop new and better treatments.
Current treatments don't work for everyone with inflammatory bowel disease, and doctors still don't fully understand what causes these conditions. This study aims to fill that gap by identifying the underlying immune system and genetic abnormalities, which could lead to more effective therapies tailored to individual patients.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll be asked to donate blood samples and may be invited to undergo an upper endoscopy or colonoscopy so doctors can collect small tissue samples from your intestines. You'll also share your medical history and clinical information relevant to your bowel disease. Participation can happen either at the NIH Clinical Center as an inpatient or outpatient visit, or by mail if you're providing samples remotely. The study is ongoing, and researchers may contact you periodically to update your medical information.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States